Michael Salinger is a panelist on the topic of “Payment Innovation” and CRA is a sponsor of this event.
For more information, click here.
What’s 340B? An economist’s view of the recent wave of 340B litigation
But this change has led to complex relationships among pharmaceutical manufacturers, hospitals, pharmacies, and third-party administrators, increasing...
